CFN Media Group ("CannabisFN"), the leading creative agency and
media network dedicated to legal cannabis, announces publication of
an article discussing Future Farm Technologies Inc. (CSE:
FFT) (CNSX: FFT) (FFT.CN) (OTCQB: FFRMF), and its place in the
expanding market for cannabinoids, the active ingredients in the
cannabis plant.
Cannabinoid Pharmaceuticals
The market for cannabinoid-based pharmaceuticals
is projected to grow from $2 billion in 2020 to more than $50
billion by 2029, according to Statista, driven by increasing
interest among pharmaceutical companies. While GW Pharmaceuticals
plc and Insys Therapeutics Inc. may be the most widely known
companies in the space, many smaller companies have
development-stage programs in the works.
Cannabinoid compounds, like cannabidiol (CBD),
have demonstrated promise in treating many different underlying
medical conditions without the side effects of traditional
pharmaceutical drugs. According to Google Scholar, there have
been more than 2,000 papers published about CBD this year alone.
Many companies have also become increasingly interested in the
therapeutic potential for the cannabinoid, as evidenced by the more
than 1,600 U.S. patents that have been issued mentioning
CBD. For example, GW Pharmaceuticals’ Sativex® has been shown to be
effective in treating central and peripheral neuropathic pain,
rheumatoid arthritis, and cancer pain in numerous randomized
clinical trials and has far fewer side effects than addictive
opioids.
The traditional pharmaceutical industry has
largely steered clear of the cannabinoid-based industry due to the
legal status of cannabis in the United States. With many of these
companies facing so-called patent cliffs over the coming years, and
cannabis legalization taking hold across the U.S., smaller
companies with promising clinical programs could see interest on
the part of larger pharmaceutical companies looking to expand their
portfolios. Cannabinoids are being studied for treatment of many
multi-billion dollar conditions including psoriasis/skin
conditions, epilepsy, Parkinson's disease, inflammation, and
pain.
Future Farm’s Unique Position
Future Farm Technologies Inc. (CSE: FFT) (OTCQB:
FFRMF) is laying the groundwork to supply the cannabinoids for this
expanding market. Though cannabis is federally illegal, the hemp
version of the plant is not. Hemp provides CBD and other
cannabinoids, it just needs to be grown with those characteristics
emphasized to produce the maximum amount of the right type of
cannabinoids. Future Farm is partnered with one of the
worlds’ leading agro-biotechnology companies, Rahan Meristem Ltd.,
to create and clone the hemp plants with just such
characteristics.
The company also features a closed-loop
liquid-liquid phase extraction system that can draw out the
cannabinoids from the hemp plant efficiently and effectively. The
extracts are a fast-growing segment of both the medical and
adult-use marijuana sectors to be sure, offering Future Farm a
potentially lucrative revenue stream. These extracts can also be
used to supply cannabinoid pharmaceutical research.
Expanding Footprint in Hemp
With the ability to create and replicate hemp
plants with the desired cannabinoid profile, as well as the
technology to extract those cannabinoids, Future Farm set about
securing a hemp supply. The company recently
announced that it has signed a lease agreement for 100-acres
in Maine, which doubles its previously announced purchase
of 120 acres of a licensed industrial hemp farm. As part of the
agreement, the company has an option to lease up to an additional
1,000 acres from the landlord, which creates an enormous market
opportunity as demand for hemp and its extracts rises over
time.
Management is preparing to set up a clone
operation, which will leverage vertical farming technology to
supply over 200,000 clones to the farm next year. These hemp-based
clones will be grown under its Scorpion LED grow lights to help
save on electricity costs and further leverage its existing
in-house technologies. The lease agreement also provides all other
farming equipment needed to commence hemp farming activities.
“This lease agreement positions us in the hemp
farming and CBD business for growing, researching, developing, and
selling organic hemp and CBD oil, which contains a broad range of
cannabinoids used to treat a growing population of CBD oil
consumers,” said Future Farm CEO Bill Gildea. “We look forward to a
very busy 2018 with our hemp and cannabis operations positioned on
both coasts to meet the exploding demand of THC and CBD oil.”
Looking Ahead
Future Farm Technologies Inc. (CSE: FFT) (OTCQB:
FFRMF) is well positioned to capitalize on the growing demand for
CBD and other cannabinoids, not only in the pharmaceutical
development industry but in the existing and growing consumer
market, using its full-spectrum of in-house technologies.
Please follow the link to read the full
article: http://www.cannabisfn.com/future-farm-strengthens-foothold-hemp-based-cbd-market/
For more information, visit the company’s website
at www.futurefarmtech.com.
About CFN Media
CFN Media (CannabisFN) is the leading creative
agency and media network dedicated to legal cannabis. We help
marijuana businesses attract investors, customers (B2B, B2C),
capital, and media visibility. Private and public marijuana
companies and brands in the US and Canada rely on CFN Media to grow
and succeed.
Learn how to become a CFN Media client company,
brand or
entrepreneur: http://www.cannabisfn.com/featuredcompany
Download the CFN Media iOS mobile app to access
the world of cannabis from the palm of your
hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8
Or visit our homepage and enter your mobile number
under the Apple App Store logo to receive a download link text on
your iPhone: http://www.cannabisfn.com
Disclaimer:
Except for the historical information presented
herein, matters discussed in this release contain forward-looking
statements that are subject to certain risks and uncertainties that
could cause actual results to differ materially from any future
results, performance or achievements expressed or implied by such
statements. Emerging Growth LLC, which owns CFN Media and
CannabisFN.com, is not registered with any financial or securities
regulatory authority, and does not provide nor claims to provide
investment advice or recommendations to readers of this release.
Emerging Growth LLC may from time to time have a position in the
securities mentioned herein and may increase or decrease such
positions without notice. For making specific investment decisions,
readers should seek their own advice. Emerging Growth LLC may be
compensated for its services in the form of cash-based compensation
or equity securities in the companies it writes about, or a
combination of the two. For full disclosure please
visit: http://www.cannabisfn.com/legal-disclaimer/
CFN Media
Frank Lane
206-369-7050
flane@cannabisfn.com
Future Farm Technologies (CSE:FFT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Future Farm Technologies (CSE:FFT)
Historical Stock Chart
From Apr 2023 to Apr 2024
